Quantum Biopharma (QNTM) Cash from Discontinued Operations (2019 - 2022)
Quantum Biopharma's Cash from Discontinued Operations history spans 4 years, with the latest figure at 504264.0 for Q1 2022.
- On a quarterly basis, Cash from Discontinued Operations fell 175.04% to 504264.0 in Q1 2022 year-over-year; TTM through Mar 2022 was 2558318.0, a 1725.79% decrease, with the full-year FY2022 number at 1142982.0, up 17.3% from a year prior.
- Cash from Discontinued Operations hit 504264.0 in Q1 2022 for Quantum Biopharma, up from 2608536.0 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for QNTM hit a ceiling of 1539547.64 in Q1 2019 and a floor of 2608536.0 in Q4 2021.
- Historically, Cash from Discontinued Operations has averaged 95712.48 across 4 years, with a median of 80935.53 in 2020.
- Biggest five-year swings in Cash from Discontinued Operations: soared 930.31% in 2021 and later plummeted 175.04% in 2022.
- Tracing QNTM's Cash from Discontinued Operations over 4 years: stood at 1539547.64 in 2019, then crashed by 106.4% to 98471.34 in 2020, then plummeted by 2549.03% to 2608536.0 in 2021, then skyrocketed by 80.67% to 504264.0 in 2022.
- Business Quant data shows Cash from Discontinued Operations for QNTM at 504264.0 in Q1 2022, 2608536.0 in Q4 2021, and 314573.0 in Q3 2021.